“…Intestinal IgA is one such immune component that preferentially targets colitogenic members of the microbiota, including SFB and A. muciniphila (34,39,41,56,57). Reciprocally, certain pathobionts can produce proteolytic enzymes that degrade intestinal IgA and thereby enhance colitis susceptibility (40).…”